The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
08 Apr 2021
Historique:
received: 30 11 2020
revised: 18 01 2021
accepted: 12 02 2021
pubmed: 7 3 2021
medline: 25 11 2021
entrez: 6 3 2021
Statut: ppublish

Résumé

We estimated the 2020 European Society of Cardiology-Acute Cardio Vascular Care (ESC-ACVC) quality indicators (QI) for the management of acute myocardial infarction, from three existing registries to determine the feasibility of assessment, room for improvement, association with outcomes, and suitability for centre benchmarking. Data were extracted from three French nationwide registries, namely FAST-MI 2005, 2010, and 2015. Feasibility of assessment and room for improvement were estimated by the denominator (patients in whom QI could be measured) and numerator (patients who satisfied the QI, among those eligible). Associations between composite QIs (CQIs) and mortality were assessed by multivariate analysis. Centre benchmarking was based on the centres mean CQI, vs. the national mean. The 2020 QIs were measured in 12 660/13 130 patients from FAST-MI. Measurement feasibility ranged from 15% to 100% with greater potential for implementation with the 2020 QI set. The mean (±SD) value of the opportunity-based CQI was 0.72 ± 0.01 and attainment of the all-or-none CQI 8.5%. Both CQIs were associated with adjusted 1-year mortality. Centre categorization into low, intermediate, and high quality was feasible, and distinguished centres with differing mortality. Most of the 2020 QI can be measured from existing registries in all domains but not in the patient's satisfaction domain. This assessment shows potential for implementation. Both CQIs were inversely associated with one-year mortality and centre benchmarking was feasible.

Identifiants

pubmed: 33675658
pii: 6155883
doi: 10.1093/ehjacc/zuab010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-215

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

François Schiele (F)

Department of Cardiology, University Hospital Besancon, Boulevard Fleming, Besancon 25000, France.
EA3920, University of Franche-Comté, Besancon 25000, France.

Chris P Gale (CP)

University of Leeds, Leeds, UK.

Tabassome Simon (T)

Department of Clinical Pharmacology and Unité de Recherche Clinique (URCEST), Hôpital Saint Antoine, AP-HP, Paris, France.
Université Pierre et Marie Curie (UPMC-Paris, 06), Paris, France.
INSERM U-698, Paris, France.

Keith A A Fox (KAA)

Centre for Cardiovascular Science, University of Edinburgh, UK.

Hector Bueno (H)

Cardiology Department, Hospital Universitario 12 de Octubre and Instituto de Investigación Sanitaria Hospital, 12 de Octubre (imas12), Madrid, Spain.
CIBER de enfermedades CardioVasculares (CIBERCV), Madrid, Spain.
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Maddalena Lettino (M)

Cardiovascular Department, San Gerardo Hospital, ASST-Monza, Monza, Italy.

Marco Tubaro (M)

San Filippo Neri Hospital, Rome, Italy.

Etienne Puymirat (E)

Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Cardiology, Hôpital Européen Georges Pompidou, Paris, France.
Université Paris-Descartes, Paris, France.
INSERM U-970, Paris, France.

Jean Ferrières (J)

Department of Cardiology, Toulouse Rangueil University Hospital, Toulouse University School of Medicine, Toulouse, France.
Department of Epidemiology and Public Health, INSERM-Université de Toulouse, UMR 1027, Toulouse, France.

Fiona Ecarnot (F)

Department of Cardiology, University Hospital Besancon, Boulevard Fleming, Besancon 25000, France.
EA3920, University of Franche-Comté, Besancon 25000, France.

Nicolas Danchin (N)

Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Cardiology, Hôpital Européen Georges Pompidou, Paris, France.
Université Paris-Descartes, Paris, France.

Nicolas Meneveau (N)

Department of Cardiology, University Hospital Besancon, Boulevard Fleming, Besancon 25000, France.
EA3920, University of Franche-Comté, Besancon 25000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH